Filing Details

Accession Number:
0001641172-25-004955
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-16 06:08:22
Reporting Period:
2025-04-15
Filing Date:
2025-04-16
Accepted Time:
2025-04-16 06:08:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1574094 Renovorx Inc. RNXT Pharmaceutical Preparations (2834) 271448452
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1862613 Shaun Bagai C/O Renovorx, Inc.
2570 W El Camino Real, Suite 320
Mountain View CA 94040
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-04-15 7,500 $0.91 320,040 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects open market purchases of the Issuer's securities.